About US
Contact us
-
Roche produces 'hidden billionaires' as cancer drugs dominateRoche ($RHHBY) shares quickly ticked up today after the FDA approved its highly anticipated breast treatment Kadcyla. That will only add to the wealth of a dozen shareholders tied to the families tha2013/2/25
-
Affymax, Takeda pull Omontys after fatal allergic reactionsSevere hypersensitivity reactions in Omontys patients prompted Affymax ($AFFY) and Takeda Pharmaceutical to recall all lots of the anemia drug, designed for use in dialysis patients. Some of the reac2013/2/25
-
ILE Pharmaceutical Materials Co. sincerely invites you to visit CPhI South East Asia 2013ILE Pharmaceutical Materials Co. sincerely invites you to visit CPhI South East Asia 2013Date: 20 – 22 March, 2013Address: Jakarta International Expo – Kemayoran, Indonesia ILE Stand No.: JCA01 (CC2013/2/22
-
German cost agency spurns Xalkori, KomboglyzeThe well-armed German pricing gatekeepers have dismissed two more Big Pharma drugs. Pfizer's ($PFE) lung cancer treatment Xalkori and the Bristol-Myers Squibb ($BMY)/AstraZeneca ($AZN) diabetes drug2013/2/22
-
Lyrica matches UCB drug in Pfizer's latest epilepsy trialPfizer's attempts to prove Lyrica effective as an epilepsy treatment have delivered mixed results. Just three months ago, the controlled-release formula failed a Phase III trial in adults with epilep2013/2/22
-
Pfizer demands rehearing in generic Reglan casePfizer ($PFE) asked the Alabama Supreme Court to think twice before allowing generics patients to sue branded drugmakers. The company filed for a rehearing yesterday, after the state's top court det2013/2/20
-
Italian antitrust agency probes alleged Roche-Novartis cartelItalian antitrust watchdogs have entered the Avastin-vs.-Lucentis fray. The Italian Competition Authority opened an investigation of Roche ($RHHBY) and Novartis ($NVS) on suspicion of a "cartel" des2013/2/20
-
GSK, Roche teaming with anti-doping agencyDrugmakers have watched their products become performance-enhancing tools for athletes for years. Steroids, human grown hormone and the now-notorious EPO, among others, came out of Big Pharma's labs2013/2/20
-
Novartis nabs another FDA-approved indication for everolimusTurns out, everolimus is becoming quite the franchise for Novartis ($NVS). Sold under the Afinitor and Votubia names for tumor treatment and as Zortress and Certican for transplant patients, everoli2013/2/19
-
Pfizer shutters CovX research operation in San DiegoPfizer ($PFE) is closing its CovX R&D operation in San Diego a little more than four years after buying the biotech company. About 100 jobs will be lost in the shudown2013/2/19